PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17935135-7	2008	Using TBB, an inhibitor of protein kinase CK2, we showed that CK2 was required for hypoxia-induced HDAC activation.	2-ethylhexyl 2,3,4,5-tetrabromobenzoate	6-9	histone deacetylase 9	Homo sapiens	99-103	
17935135-12	2008	Use of Apicidin (an HDAC inhibitor) and TBB revealed that CK2-dependent HDAC activation contributed to pVHL downregulation and HIF-1alpha stabilization under hypoxia.	2-ethylhexyl 2,3,4,5-tetrabromobenzoate	40-43	histone deacetylase 9	Homo sapiens	72-76	
32218358-3	2020	Using tetrabromobenzotriazole (TBB) and 2-dimethylamino-4,5,6,7-tetrabromo-benzimidazole (DMAT) as scaffolds for CK2 inhibition, and a hydroxamate to coordinate the zinc atom present in the active site of HDAC (zinc binding group, ZBG), new multitarget inhibitors have been designed and synthesized.	2-ethylhexyl 2,3,4,5-tetrabromobenzoate	31-34	histone deacetylase 9	Homo sapiens	205-209